DSV has launched a new Luxembourg (LUX) to Indianapolis International (IND) pharma air route to improve temperature-controlled deliveries.
This dedicated connection between Luxembourg and Indianapolis connect two critical nodes in the global pharmaceutical supply chain, said the freight forwarder.
Indianapolis is one of the US’ fastest-growing life sciences and healthcare logistics hubs.
The latest expansion of the Air ThermoDirect healthcare network will minimise the time shipments spend in uncontrolled environments and remove the complexity of active containers, explained DSV.
This is designed to help pharmaceutical companies protect product integrity while lowering total cost, emissions and operational uncertainty across critical lanes.
“The DSV Indianapolis operations will play a pivotal role in the global Air ThermoDirect healthcare network, enhancing end to end visibility and control across pharma manufacturing regions in the US, Europe, the Americas, and APAC,” said Kenneth Källström, executive vice president, global head, healthcare, DSV.
“By strengthening these critical supply chain connections, this hub will help ensure that life saving therapies move with greater speed, reliability, and integrity — ultimately delivering better outcomes for patients worldwide.”
Stephanie Penarete, vice president Air Product Americas, DSV, added: “Indy Wings reflects our strategy to bring the critical points of the supply chain under full accountability, ensuring reliability, integrity and performance where it matters most.
“With Indy Wings, we continue linking key pharmaceutical hubs with greater precision, resilience and excellence.”
